Literature DB >> 30372424

TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation.

Cun-Jin Zhang1,2,3, Meiling Jiang1,3,4, Hao Zhou3, Weiwei Liu3, Chenhui Wang3,5,6, Zizhen Kang3, Bing Han3, Quanri Zhang3, Xing Chen3, Jianxin Xiao3, Amanda Fisher7, William J Kaiser7, Masanori A Murayama8,9, Yoichiro Iwakura9, Ji Gao10, Julie Carman10, Ashok Dongre10, George Dubyak11, Derek W Abbott12, Fu-Dong Shi2,13, Richard M Ransohoff14, Xiaoxia Li3.   

Abstract

NLRP3 inflammasome plays a critical spatiotemporal role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). This study reports a mechanistic insight into noncanonical NLRP3 inflammasome activation in microglia for the effector stage of EAE. Microglia-specific deficiency of ASC (apoptosis-associated speck-like protein containing a C-terminal caspase-activation and recruitment [CARD] domain) attenuated T cell expansion and neutrophil recruitment during EAE pathogenesis. Mechanistically, TLR stimulation led to IRAKM-caspase-8-ASC complex formation, resulting in the activation of caspase-8 and IL-1β release in microglia. Noncanonical inflammasome-derived IL-1β produced by microglia in the CNS helped to expand the microglia population in an autocrine manner and amplified the production of inflammatory cytokines/chemokines. Furthermore, active caspase-8 was markedly increased in the microglia in the brain tissue from patients with multiple sclerosis. Taken together, our study suggests that microglia-derived IL-1β via noncanonical caspase-8-dependent inflammasome is necessary for microglia to exert their pathogenic role during CNS inflammation.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; Inflammation

Mesh:

Substances:

Year:  2018        PMID: 30372424      PMCID: PMC6264724          DOI: 10.1172/JCI121901

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

2.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

3.  The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore.

Authors:  Mastura Monif; Christopher A Reid; Kim L Powell; Megan L Smart; David A Williams
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

Review 4.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

Review 5.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

6.  NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.

Authors:  Makoto Inoue; Kristi L Williams; Michael D Gunn; Mari L Shinohara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-13       Impact factor: 11.205

Review 7.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

8.  T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis.

Authors:  Bradley N Martin; Chenhui Wang; Cun-jin Zhang; Zizhen Kang; Muhammet Fatih Gulen; Jarod A Zepp; Junjie Zhao; Guanglin Bian; Jeong-su Do; Booki Min; Paul G Pavicic; Caroline El-Sanadi; Paul L Fox; Aoi Akitsu; Yoichiro Iwakura; Anasuya Sarkar; Mark D Wewers; William J Kaiser; Edward S Mocarski; Marc E Rothenberg; Amy G Hise; George R Dubyak; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Immunol       Date:  2016-03-21       Impact factor: 25.606

9.  GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes.

Authors:  Robin A Aglietti; Alberto Estevez; Aaron Gupta; Monica Gonzalez Ramirez; Peter S Liu; Nobuhiko Kayagaki; Claudio Ciferri; Vishva M Dixit; Erin C Dueber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-23       Impact factor: 11.205

10.  Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.

Authors:  Francesca Ronchi; Camilla Basso; Silvia Preite; Andrea Reboldi; Dirk Baumjohann; Luana Perlini; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Commun       Date:  2016-05-18       Impact factor: 14.919

View more
  36 in total

Review 1.  Metabolic regulation of inflammasomes in inflammation.

Authors:  Qiuli Yang; Ruichen Liu; Qing Yu; Yujing Bi; Guangwei Liu
Journal:  Immunology       Date:  2019-04-08       Impact factor: 7.397

2.  Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis.

Authors:  Bart Tummers; Luigi Mari; Clifford S Guy; Bradlee L Heckmann; Diego A Rodriguez; Sebastian Rühl; Julien Moretti; Jeremy Chase Crawford; Patrick Fitzgerald; Thirumala-Devi Kanneganti; Laura J Janke; Stephane Pelletier; J Magarian Blander; Douglas R Green
Journal:  Immunity       Date:  2020-05-18       Impact factor: 31.745

3.  Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells.

Authors:  De-Huang Guo; Masaki Yamamoto; Caterina M Hernandez; Hesam Khodadadi; Babak Baban; Alexis M Stranahan
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 4.  Inflammasome activation and regulation: toward a better understanding of complex mechanisms.

Authors:  Danping Zheng; Timur Liwinski; Eran Elinav
Journal:  Cell Discov       Date:  2020-06-09       Impact factor: 10.849

5.  Remifentanil inhibits the inflammatory response of BV2 microglia and protects PC12 cells from damage caused by microglia activation.

Authors:  Yankui Huang; Qingxiang Cai; Huihui Liu; Yong Wang; Wuhua Ma
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis.

Authors:  Debolina D Biswas; Rebecca K Martin; LaShardai N Brown; Karli Mockenhaupt; Angela S Gupta; Michael J Surace; Anuj Tharakan; Jessie W Yester; Reetika Bhardwaj; Daniel H Conrad; Tomasz Kordula
Journal:  J Neuroinflammation       Date:  2022-06-19       Impact factor: 9.587

Review 7.  Immunoneuropsychiatry - novel perspectives on brain disorders.

Authors:  Marion Leboyer; Frauke Zipp; Katrin Pape; Ryad Tamouza
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

8.  Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis.

Authors:  Katarzyna Bulek; Junjie Zhao; Yun Liao; Nitish Rana; Daniele Corridoni; Agne Antanaviciute; Xing Chen; Han Wang; Wen Qian; William A Miller-Little; Shadi Swaidani; Fangqiang Tang; Belinda B Willard; Keith McCrae; Zizhen Kang; George R Dubyak; Fabio Cominelli; Alison Simmons; Theresa T Pizarro; Xiaoxia Li
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

9.  Temporal and Spatial Dynamics of Inflammasome Activation After Ischemic Stroke.

Authors:  Danli Lu; Mengyan Hu; Bingjun Zhang; Yinyao Lin; Qiang Zhu; Xuejiao Men; Zhengqi Lu; Wei Cai
Journal:  Front Neurol       Date:  2021-04-22       Impact factor: 4.003

Review 10.  Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease.

Authors:  Agata Matejuk; Arthur A Vandenbark; Halina Offner
Journal:  Front Neurol       Date:  2021-05-31       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.